Trend Seen for Improved Recurrence-Free Survival With Pembrolizumab in Merkel Cell Carcinoma

THURSDAY, Oct. 23, 2025 (HealthDay News) -- For patients with resected Merkel cell carcinoma (MCC), adjuvant pembrolizumab yields a trend toward improved recurr

See Full Page

Interests (0)

Settings

Trend Seen for Improved Recurrence-Free Survival With Pembrolizumab in Merkel Cell Carcinoma

Florida to End Childhood Vaccination Mandates

Kim Kardashian Reveals She Was Diagnosed with a Brain Aneurysm

'Unreasonable': Vulnerable Republican blasts saving health care subsidies for millions

Critics say taxpayer funds for nursing homes shouldn't be spent on new buildings

Shutdown leaves gaps in states’ health data, possibly endangering lives

Kim Kardashian Diagnosed With Brain Condition And Blames Kanye West

The Best Time to Eat Garlic for Immunity, Heart Health, Inflammation, and Digestion

Why Can’t All Pregnancy Care Be Like Abortion Care?

Therapy dog awakens woman from coma at Pembroke Pines hospital

Trump’s crew may be spreading asbestos with unpermitted White House teardown: expert

Delirium Risk Increased for Seniors Prescribed First

SGLT-2 Inhibitors Tied to Lower Risk for Autoimmune Rheumatic Diseases in Adults With T2D

Social-Environment Factors Linked to Brain Structure, Function

Virginia Giuffre's co-writer says she knows the Epstein list names

Trump Administration Moves to Lift National Guard Deployment Ban in Portland

Woman speaks out after sentencing of man who confessed on Facebook to sexual assault

White House Begins Demolition of East Wing for New Ballroom

'Just felt it was time': Trump explains decision to elevate sanctions on Russia

Iceland just found its first mosquitoes

Details Emerge on Funding for New White House Ballroom

Trump pardons convicted Binance founder 'CZ' Zhao

Biden completes a round of radiation therapy as part of his prostate cancer treatment

Man who planned to shoot up Atlanta's airport is arrested in a terminal following a tip, police say